ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. (Q37023688)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 October 2015
edit
Language Label Description Also known as
English
ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
scientific article published on 12 October 2015

    Statements

    ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit